Matthew D Blunt
15PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Jan 13, 2026
CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A.Lara V Graham, Russell B Foxall, Margaret Ashton-Key
|Sep 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis.Lara V Graham, Ludmila Horehajova, Marco V Haselager
|Apr 28, 2025
Modulation of anti-tumour immunity by XPO1 inhibitors.Jack G Fisher, Laura G Bartlett, Trinayan Kashyap
|Aug 29, 2024
NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity.Lara V Graham, Salim I Khakoo, Matthew D Blunt
|Aug 23, 2024
The nuclear export protein XPO1 provides a peptide ligand for natural killer cells.Matthew D Blunt, Hayden Fisher, Ralf B Schittenhelm
Pageof 3
Frequent Collaborators
6 joint publications
Salim I Khakoo
4 joint publications
Jack G Fisher
4 joint publications
Mark S Cragg
4 joint publications
Lara V Graham
3 joint publications
Amber D P Doyle
3 joint publications
Francesco Forconi
2 joint publications
Peter W M Johnson
1 joint publications
Andres Vallejo Pulido
1 joint publications
Marta Polak
1 joint publications
Dean Bryant
